Spoken Alpha
Praxis Precision Medicines, Inc.
Praxis Precision Medicines designs and develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance, primarily focusing on genetic epilepsies and movement disorders.
Praxis Precision Medicines, Inc is a Healthcare company operating in Biotechnology with a $8.67B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 3, 2026).
7 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PRAX.
$ curl https://api.spokenalpha.com/v1/companies/PRAXFAQ
Spoken Alpha indexes PRAX's earnings call transcripts at https://spokenalpha.com/companies/PRAX. Each call links to attributed speakers and parsed analyst Q&A.
Praxis Precision Medicines, Inc. (PRAX) held its most recent earnings call on 2026-05-09, covering fiscal Q1 2026.
Praxis Precision Medicines, Inc. (PRAX) operates in the Healthcare sector (Biotechnology industry).
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-03 | — | $-3.65 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-05 | $-2.87 | $-3.60 | +20.3% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $-3.20 | $-3.68 | +13.0% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-02-18 | $-3.50 | $-3.13 | -11.8% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-04 | $-3.36 | $-3.45 | +2.6% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-03 | $-3.31 | $-3.36 | +1.5% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-01 | $-3.29 | $-3.21 | -2.5% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-02 | $-2.94 | $-2.82 | -4.3% | $7.5M | — | — | EODHD |
| Q3 FY2024 | 2024-11-05 | $-2.75 | $-1.95 | -41.0% | $302.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-12 | $-1.74 | $-2.32 | +25.0% | $357.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-12 | $-2.84 | $-2.16 | -31.5% | $431.0K | — | — | EODHD |
| Q4 FY2023 | 2024-03-04 | $-2.97 | $-3.18 | +6.6% | $515.0K | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-2.70 | $-4.89 | +44.8% | $468.0K | — | — | EODHD |
| Q2 FY2023 | 2023-08-08 | $-7.35 | $-10.60 | +30.7% | $781.0K | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-10.65 | $-12.80 | +16.8% | $683.0K | — | — | EODHD |
| Q4 FY2022 | 2023-02-06 | $-13.05 | $-12.03 | -8.5% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-08 | $-14.40 | $-14.01 | -2.8% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-07 | $-19.80 | $-19.27 | -2.8% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-08 | $-1.51 | $-1.30 | -16.2% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-02-27 | $-19.50 | $-16.05 | -21.5% | $0 | — | — | EODHD |
Source: EODHD. PRAX reported actuals as published; sparse fields render as —.